Skip to main content
. 2020 Jan 16;2020(1):CD013203. doi: 10.1002/14651858.CD013203.pub2

Belli 2001.

Methods Randomised clinical trial
Participants Country: Italy
 Period of recruitment: 1997‐1999
 Number randomised: 19
 Post‐randomisation dropouts: not stated
 Revised sample size: 19
 Average age (years): not stated
 Females: not stated
 Primary transplantation: not stated
 Reason for transplantation
Alcohol‐related cirrhosis: not stated
 Viral‐related cirrhosis: not stated
 Autoimmune disease‐related cirrhosis: not stated
 HCC: not stated
 Others: not stated
 Maintenance immunosuppression used during induction immunosuppression: cyclosporin A plus azathioprine
 Altered immunosuppression after withdrawal: yes (azathioprine was dropped)
Interventions Group 1: anti‐thymocyte globulin (n = 8)
 Further details: Rabbit anti‐thymocyte globulin for 5 days (no further details on the dose, frequency)
 Group 2: anti‐thymocyte globulin + glucocorticosteroids (n = 11)
 Further details: rabbit anti‐thymocyte globulin for 5 days + glucocorticosteroids for 3 months (no further details on the dose, frequency)
Outcomes Outcomes reported: graft rejection (any)
 Follow‐up (months): 22
Notes Source of funding: not stated
 Trial name/trial registry number: not stated
 Attempts were made to contact the authors in August 2019.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Comment: this information was not available
Allocation concealment (selection bias) Unclear risk Comment: this information was not available
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Comment: this information was not available
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Comment: this information was not available
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Comment: this is a three‐armed trial, but only two arms are eligible for inclusion in the review. There were post‐randomisation dropouts. The number of dropouts in each group and the reasons for dropouts were not reported
Selective reporting (reporting bias) High risk Comment: no pre‐published protocol was available and the authors did not report on mortality, graft loss, or adverse events
Other bias Low risk Comment: no other bias noted